antibody against D antigen, the most immunogenic of the antigenic markers of the Rh blood group. Commercial preparations of anti-D, Rh0 (D) immune globulin, are administered to Rh-negative women following the birth of Rh-positive infants in order to prevent incompatibility of maternal blood with the D-antigen, which may cause erythroblastosis fetalis in a subsequent pregnancy. Called also anti-Rh0.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.